Product

WCK 6777

1 clinical trial

1 indication

Indication

Bacterial infection

Clinical trial

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777) In Healthy Adult Subjects

Status: Completed, Estimated PCD: 2023-11-03